Download PDF
Thromb Haemost 1978; 40(02): 578-580
DOI: 10.1055/s-0038-1648697
Letter to the Editor
Schattauer GmbH Stuttgart

Urokinase I and II Activity

M Samama
Laboratoire Central d’Hématologie, Hotel Dieu - Paris 75004
,
B Cazenave
Laboratoire Central d’Hématologie, Hotel Dieu - Paris 75004
,
A M Otero
Laboratoire Central d’Hématologie, Hotel Dieu - Paris 75004
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Collen D, De Cock F, Verstraete M. 1975; Immunochemical distinction between antiplasmin and alpharantitrypsin. Thrombosis Research 7: 245
    CrossrefPubMedGoogle Scholar
  • 2 Johnson AJ, Kline DL, Alkjaersig N. 1969; Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems(1967-68). Thrombosis et Diathesis Haemorrhagica 21: 259
    PubMedGoogle Scholar
  • 3 Lormeau JC, Goulay J, Vairel EG, Choay J. 1978. A comment on the activities of high and low molecular weight urokinase. In: Gaffney PJ, Balkuv-Ulitin S. (ed.) Fibrinolyis: Current Fundamental and Clinical Concepts. Pub. Academic Press; London: pp 77-82
    Google Scholar
  • 4 Prentice CR M, Thomson C, Forbes CD. 1975. Endogenous inhibitors of the fibrinolytic enzyme system. In: Davidson JF, Samama MM, Desnoyers PC. (ed.) Progress in Chemical Fibrinolysis and Thrombosis. Raven Press; New York: pp 209
    Google Scholar
  • 5 UPETI: Urokinase pulmonary embolism trial national cooperative study. 1973; Circulation. 47 supplément (Suppl. 02) 1
    PubMedGoogle Scholar
  • 6 UPET II. 1974; Urokinase streptokinase pulmonary embolism trial: Phase 2 results. Journal of the American Medical Association 229: 1606
    CrossrefPubMedGoogle Scholar